B S Katzenellenbogen - JoVE Visualize

Showing results (121-130 of 168) with videos related to

Pageof 17

Sort By:

Molecular Endocrinology (Baltimore, Md.)|March 1, 1996

Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogensM M Montano, K Ekena, K D Krueger, et al.

Bioorganic & Medicinal Chemistry Letters|September 11, 2001

Furans with basic side chains: synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor alphaD S Mortensen, A L Rodriguez, J Sun, et al.

Molecular Endocrinology (Baltimore, Md.)|June 1, 1992

Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cellsC H Wooge, G M Nilsson, A Heierson, et al.

Cancer Research|January 1, 1984

Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cellsB S Katzenellenbogen, M J Norman, R L Eckert, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999

An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogensM M Montano, K Ekena, R Delage-Mourroux, et al.

Journal of Medicinal Chemistry|May 1, 1987

Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivativesJ A Zablocki, J A Katzenellenbogen, K E Carlson, et al.

The Journal of Biological Chemistry|October 15, 1989

Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptorK W Harlow, D N Smith, J A Katzenellenbogen, et al.

Steroids|November 1, 1986

[125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity labelF G Salituro, K E Carlson, J F Elliston, et al.

Endocrinology|July 1, 1984

Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogenF J Monsma, B S Katzenellenbogen, M A Miller, et al.

Molecular Endocrinology (Baltimore, Md.)|August 26, 1998

Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-monophosphate but not estradiolJ W Clemens, R L Robker, W L Kraus, et al.

Pageof 17

Showing results (121-130 of 168) with videos related to

Sort By:

Pageof 17

Molecular Endocrinology (Baltimore, Md.)|March 1, 1996

Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogensM M Montano, K Ekena, K D Krueger, et al.

Bioorganic & Medicinal Chemistry Letters|September 11, 2001

Furans with basic side chains: synthesis and biological evaluation of a novel series of antagonists with selectivity for the estrogen receptor alphaD S Mortensen, A L Rodriguez, J Sun, et al.

Molecular Endocrinology (Baltimore, Md.)|June 1, 1992

Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cellsC H Wooge, G M Nilsson, A Heierson, et al.

Cancer Research|January 1, 1984

Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cellsB S Katzenellenbogen, M J Norman, R L Eckert, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999

An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogensM M Montano, K Ekena, R Delage-Mourroux, et al.

Journal of Medicinal Chemistry|May 1, 1987

Estrogenic affinity labels: synthesis, irreversible receptor binding, and bioactivity of aziridine-substituted hexestrol derivativesJ A Zablocki, J A Katzenellenbogen, K E Carlson, et al.

The Journal of Biological Chemistry|October 15, 1989

Identification of cysteine 530 as the covalent attachment site of an affinity-labeling estrogen (ketononestrol aziridine) and antiestrogen (tamoxifen aziridine) in the human estrogen receptorK W Harlow, D N Smith, J A Katzenellenbogen, et al.

Steroids|November 1, 1986

[125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity labelF G Salituro, K E Carlson, J F Elliston, et al.

Endocrinology|July 1, 1984

Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogenF J Monsma, B S Katzenellenbogen, M A Miller, et al.

Molecular Endocrinology (Baltimore, Md.)|August 26, 1998

Hormone induction of progesterone receptor (PR) messenger ribonucleic acid and activation of PR promoter regions in ovarian granulosa cells: evidence for a role of cyclic adenosine 3',5'-monophosphate but not estradiolJ W Clemens, R L Robker, W L Kraus, et al.

Pageof 17